Vanderbilt Vaccine Center
-
Alexander’s visit highlights efforts to confront Ebola
Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee. Read MoreSep 24, 2014
-
Initiative seeks to develop therapies to combat Ebola
Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses. Read MoreSep 18, 2014
-
Vanderbilt Vaccine Center joins global task force to address urgent viral threat
World Health Day 2014 Shines Spotlight on Mosquito-borne Viral Diseases Female Ades aegypti mosquito. Photo courtesy of the CDC Image Library. Chikungunya virus, a vector-borne disease that is quickly spread by mosquitoes and causes victims to suffer severe fever and pain, has reached the… Read MoreApr 7, 2014
-
Multi-center effort targets lethal Ebola, Marburg viruses
Vanderbilt University researchers are collaborating in a multi-center, federally-funded project to develop ways to treat and prevent the highly lethal Ebola and Marburg virus infections. Read MoreMar 6, 2014
-
Nine faculty honored with endowed chairs
Nine Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration Jan. 22 at the Student Life Center. Read MoreJan 24, 2014
-
VUCast: Preventing the next pandemic
Researchers work to prevent possible bird flu pandemic How stars solve mysteries of the universe And conquering the video gaming industry Vandy style? All this and more in this week’s VUCast, Vanderbilt’s online newscast. Watch now. [vucastblurb]… Read MoreSep 18, 2013
-
Controversial info release aids VUMC bird flu research
Vanderbilt research shows that human antibodies to the natural strain of H5N1 also protected against a dangerous lab-created airborne strain developed several years ago by scientists in the Netherlands and at the University of Wisconsin. Read MoreSep 5, 2013
-
VU researchers ‘goldsmith’ new RSV vaccine approach
Vanderbilt vaccine researchers are using gold nanotechnology to develop a new approach to making vaccines. Read MoreJul 18, 2013
-
Grant targets new therapies for Ebola, Marburg viruses
Vanderbilt’s James Crowe Jr., M.D., and a collaborator in Texas have been awarded a $4.4 million grant from the U.S. Department of Defense to study new ways to treat and prevent Ebola and Marburg viruses. Read MoreMay 16, 2013
-
Structural snapshot hints at new influenza approach
A careful look at how the body’s natural defenses disarm virulent strains of influenza hints at the possibility of a way to fight the flu. Read MoreFeb 21, 2013
-
Repository samples help shape view of new rhinovirus
Vanderbilt researchers used a treasure trove of samples collected and stored at the Vanderbilt Vaccine Clinic (VVC) to prove a particular human rhinovirus (HRV), has been causing more than just the common cold for decades. Read MoreDec 6, 2012
-
VUMC researchers reveal darker side of common cold
Human rhinovirus (HRV), also known as the common cold, can be uncommonly serious for certain children, a study led by a Vanderbilt University Medical Center pediatrician shows. The study, published in the Dec. 28, 2011 online issue of the journal Pediatrics, shows that not only can HRV lead to hospitalization… Read MoreJan 5, 2012